A vehicle may include: a feedback device; a bio-signal sensor configured to measure a bio-signal of a user; and a controller operatively coupled to the feedback device and the bio-signal sensor, the controller including a memory configured to store at least one program instruction and processor configured to execute the at least one program instruction. The controller may be configured to: determine information characterizing a current emotional state of the user based on the bio-signal; calculate, based on a difference value between the current emotional state and a target emotional state, an operation ratio between a first mode for controlling operation of the feedback device to decrease a degree of excitability of the user and a second mode for controlling the operation of the feedback device to increase a degree of positivity of the user; and control the operation of the feedback device for a predetermined time based on the operation ratio.

Non-pharmaceutical systems and methods of treating the symptoms of fibromyalgia are described. The method includes administering a therapeutically effective amount of a sensory stimulus to a person, wherein the sensory stimulus includes one or more visual stimuli and one or more auditory stimuli.

Non-pharmaceutical systems and methods of treating the symptoms of fibromyalgia are described. The method includes administering a therapeutically effective amount of a sensory stimulus to a person, wherein the sensory stimulus includes one or more visual stimuli and one or more auditory stimuli.

The present disclosure relates to a method for determining a mouth leak status associated with a user of a respiratory device is disclosed. Airflow data associated with the user of the respiratory device is received. The respiratory device is configured to supply pressurized air to an airway of the user during a therapy session. The airflow data includes pressure data. The airflow data associated with the user is analyzed. Based at least in part on the analysis, the mouth leak status associated with the user is determined. The mouth leak status is indicative of whether or not air is leaking from a mouth of the user.

A ventilation apparatus has a breathing gas delivery system for delivering breathing gas to a user of the apparatus as ventilation therapy, with a controllable pressure and flow. The breathing pressure and flow are monitored to derive a respiration variability. A state of relaxation of the user is derived during provision of breathing assistance based on at least the respiration variability. Settings of the ventilation apparatus are then adapted dependence on the estimated state of relaxation for assisting the user in habituating to the breathing assistance, and hence habituating to breathing therapy.

A ventilation apparatus has a breathing gas delivery system for delivering breathing gas to a user of the apparatus as ventilation therapy, with a controllable pressure and flow. The breathing pressure and flow are monitored to derive a respiration variability. A state of relaxation of the user is derived during provision of breathing assistance based on at least the respiration variability. Settings of the ventilation apparatus are then adapted dependence on the estimated state of relaxation for assisting the user in habituating to the breathing assistance, and hence habituating to breathing therapy.

A method for characterizing an olfactory stimulation, including visual stimulation steps each associated with a theme and first steps of recording physiological variables carried out continuously during a first visual stimulation step, so as to obtain first physiological recordings, each first physiological recording being associated with the theme associated with the first visual stimulation step, a second olfactory stimulation step, a second step of recording values of physiological variables carried out continuously during and after the second olfactory stimulation step to obtain a second physiological recording, a step of comparing the first physiological recordings with the second physiological recording to isolate a first physiological recording close to the second physiological recording, and a step of determining a theme associated with the first physiological recording which is isolated during the comparing step.

A user interface of a respiratory therapy system includes a strap assembly, a frame, a connector, and a sensor. The strap assembly is positioned about a head of a user when the user wears the user interface. The frame is physically and electrically connected to the strap assembly, and defines an aperture. The connector has a first end portion and second end portion. The first end portion of the connector can be positioned within the aperture of the frame such that the connector is physically and electrically connected to the frame. The sensor is coupled to the strap assembly or the frame such that the sensor abuts a target area of the user when the user wears the user interface.

A computer-implemented system for training a subject to improve psychophysiological function for performance of stress-inducing activity includes a sensor interface device and a non-transitory, tangible computer readable storage medium storing computer program code. The sensor interface provides measurement of a physiological parameter of the subject, indicating stress in the subject. The computer readable storage medium stores computer code that provides a set of training segments presenting the subject with one or more visual, audible, or tactile prompts wherein at least one of the training segments simultaneously presents the subject with a stress-inducing prompt while inducing the subject to perform a relaxation-inducing protocol.

A gas therapy system (1) has a flow line (3, 2), a coupler (6) to a gas source, and an aerosol generator (4) for aerosol delivery, and a patient interface such as a nasal interface (2). A controller (10) is configured to modulate gas flow and aerosol delivery in real time. The controller changes gas flow rate and dynamically reduces aerosol delivery during upper gas flow rates such as 60 LPM, and activates aerosol delivery during lower gas flow rates of for example 10 LPM. The control may also include sensors to detect breathing, so that there is a bias towards increased aerosol delivery during inhalation in addition to during lower level gas flow.